The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q4 2021 call → NOWe need to determine if management conveys that the reported results do not represent the current business. The transcript shows management discussing record earnings, but also highlighting strategic initiatives like Bitcoin, overdraft fee elimination, merger disruption hires, digital banking, and floating rate assets. They mention that these initiatives are in motion and will impact future results. For example, they added 24 people from merger disruption, nine revenue producers. They launched a digital platform for SBA loans. They plan to enable Bitcoin transactions. They are adding floating-rate assets. They emphasize that net interest income will grow in 2022 based on balance sheet growth. They also mention that the fourth quarter had one-time items like a $2 million dividend and a $4 million compensation expense. They say that core expenses will grow high single-digit percent. They talk about the pipeline being strong. However, the question is whether they convey that the reported period is stale relative to the operating present. They do say that they are investing in the business and that the expense base will be higher as they invest. They also say that they expect loan growth to improve in 2022. But is that a clear indication that the reported numbers don't represent the current business? They are not saying that the reported period is a picture of the company before these changes. They are discussing forward-looking initiatives. The call is a typical results and outlook discussion. They mention that the fourth quarter had elevated items that will normalize. They also mention that they are adding floating-rate assets immediately. But the overall tone is that they are optimistic about the future, not that the reported period is stale. They do not say that the business as it stands today is ahead of the reported period in a substantial way. They are just giving guidance. So I think the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.